biopharmapatent

Thursday, October 27, 2016

Antibody And Epitope Patent Prosecution Tips: Part 2

The second part of my article on antibody and epitope patent prosecution tips is available law360.

https://www.law360.com/ip/articles/854935/antibody-and-epitope-patent-prosecution-tips-part-2
Posted by Paul Moradian's Pharma blog at 10:33 AM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

Wednesday, October 26, 2016

Antibody And Epitope Patent Prosecution Tips: Part 1

This article is available on law360:

https://www.law360.com/articles/854929/antibody-and-epitope-patent-prosecution-tips-part-1
Posted by Paul Moradian's Pharma blog at 10:39 AM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

Monday, October 10, 2016

Final FDA Rule Clarifies Pharma Patent Process With Aim of Reducing Unnecessary Litigation | RAPS

Final FDA Rule Clarifies Pharma Patent Process With Aim of Reducing Unnecessary Litigation | RAPS
Posted by Paul Moradian's Pharma blog at 4:35 PM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Newer Posts Older Posts Home
Subscribe to: Comments (Atom)

LinkedIn

Blog Archive

  • ►  2020 (2)
    • ►  August (1)
    • ►  April (1)
  • ►  2019 (5)
    • ►  January (5)
  • ►  2018 (4)
    • ►  December (1)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
  • ►  2017 (63)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  August (5)
    • ►  July (9)
    • ►  June (4)
    • ►  May (10)
    • ►  April (4)
    • ►  March (13)
    • ►  February (7)
    • ►  January (5)
  • ▼  2016 (23)
    • ►  December (5)
    • ►  November (6)
    • ▼  October (3)
      • Antibody And Epitope Patent Prosecution Tips: Part 2
      • Antibody And Epitope Patent Prosecution Tips: Part 1
      • Final FDA Rule Clarifies Pharma Patent Process Wit...
    • ►  September (9)

About Me

Paul Moradian's Pharma blog
View my complete profile
Payam Moradian's blog. Simple theme. Powered by Blogger.